CYLTEZO vs RIABNI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CYLTEZO and RIABNI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CYLTEZO	RIABNI
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ADALIMUMAB-ADBM	RITUXIMAB-ARRX
Manufacturer	Boehringer Ingelheim	Amgen Inc
Dosage forms	Kit	Injectable
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis	Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis

cyltezo riabni

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

ADALIMUMAB-ADBM

RITUXIMAB-ARRX

Manufacturer

Boehringer Ingelheim

Amgen Inc

Dosage forms

Kit

Injectable

Drug class

—

Boxed warning

Treats

Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis

Frequently asked questions

Which is better-rated, Cyltezo or Riabni?

Cyltezo and Riabni are tied at 3.6 out of 5 by our independent rating.

What is the difference between Cyltezo and Riabni?

Cyltezo contains Adalimumab-Adbm, while Riabni contains Rituximab-Arrx — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.